Plasma-derived product · developed by Kamada
Cytomegalovirus Immune Globulin Intravenous (Human) is an immune globulin purified from human plasma. It is being studied in transplant recipients with cytomegalovirus infection, including kidney and liver transplant patients.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT06958796 | Phase 4 | Cytomegalovirus | Recruiting | KMDA |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
CytomegalovirusKidney Transplant; ComplicationsLiver Transplant ComplicationsOrgan TransplantSimultaneous Liver-Kidney Transplantation; Complications
Updated Oct 18, 2026. Something wrong or missing? Report it on the KMDA page.
See KMDA's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
KMDA catalysts and pipeline →